Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

The Washington Post covers efforts by insurers to clamp down on doctors prescribing Ozempic, now popular as a weight loss drug, for patients who don't evidently present with diabetes. Separately, CBS ...